| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $48.1M | -3.6% |
| Cost of Revenue | $17.2M | -16.6% |
| R&D Expense | $12.4M | -19.2% |
| SG&A Expense | $10.2M | +0.4% |
| Operating Income | -$4.4M | +53.9% |
| Pre-tax Income | -$4.6M | +53.5% |
| Income Tax | $380K | +304.3% |
| Net Income | -$4.9M | +50.1% |
| EPS (Basic) | -$0.11 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $12.8M | -12.6% |
| Accounts Receivable | $7.1M | -4.4% |
| Current Assets | $22.3M | -6.4% |
| Total Assets | $43.2M | -9.0% |
| Current Liabilities | $9.3M | -4.7% |
| Total Liabilities | $10.6M | -9.0% |
| Stockholders' Equity | $32.6M | -9.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$1.1M | +74.9% |
| Capital Expenditures | $429K | -68.8% |
| Investing Cash Flow | -$429K | +67.3% |
| Financing Cash Flow | -$307K | -91.9% |
| Free Cash Flow | -$1.5M | +73.4% |
| +52.2% |
| EPS (Diluted) | -$0.11 | +52.2% |